Todd Foley, Director at Repare Therapeutics Inc. (RPTX), sold 54,134 shares at $34.42 ($1.8M) on 2021-06-09, disclosed to the SEC on 2021-06-10.
Open-market sale of $1.8M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.80 | 3,985 | $131K | 7.1% |
| 2 | $32.80 | 3,985 | $131K | 7.1% |
| 3 | $33.41 | 7,559 | $253K | 13.7% |
| 4 | $33.41 | 7,559 | $253K | 13.7% |
| 5 | $34.42 | 4,785 | $165K | 8.9% |
| 6 | $34.42 | 4,785 |
| $165K |
| 8.9% |
| 7 | $34.79 | 10,738 | $374K | 20.3% |
| 8 | $34.79 | 10,738 | $374K | 20.3% |
| Total | $34.05 avg | 54,134 | $1.8M | 100% |
| Filing → |
| ITOS | SELL | 2021-10-12 | $2.8M | — | Filing → |
| ITOS | SELL | 2021-09-20 | $5.2M | — | Filing → |
| RPTX | SELL | 2021-07-13 | $1.8M | — | Filing → |